Our Pricing

Starting Wegovy 0.5mg for Prescription Weight Loss

If you're considering starting Wegovy 0.5mg UK prescription treatment, understanding the correct dosing protocol is essential for safe and effective weight loss. Wegovy (semaglutide) follows a structured dose-escalation schedule designed to minimise side effects whilst maximising clinical outcomes, and the 0.5mg dose plays a specific role in this journey.

Can You Start Wegovy at 0.5mg in the UK?

The short answer is no — you should not start Wegovy treatment at the 0.5mg dose. The MHRA-approved dosing schedule for Wegovy in the UK begins at 0.25mg once weekly for the first four weeks [1]. This initial lower dose allows your body to adjust to semaglutide gradually, significantly reducing the likelihood of gastrointestinal side effects such as nausea, vomiting, and diarrhoea.

The 0.5mg dose is actually the second step in the Wegovy titration schedule, taken during weeks 5 through 8 of treatment [1]. Skipping the initial 0.25mg phase and starting directly at 0.5mg increases the risk of intolerable side effects that may cause you to discontinue treatment prematurely. Clinical trials demonstrated that gradual dose escalation improves treatment adherence and patient outcomes compared to starting at higher doses.

At Cured Pharmacy, our UK-registered prescribers follow the licensed Wegovy dosing protocol precisely. After your free online consultation, if Wegovy is deemed suitable for you, you'll receive a prescription that begins at the correct 0.25mg starting dose, ensuring you follow the safest and most effective treatment pathway.

The Complete Wegovy Dosing Schedule UK

Understanding the Five-Step Titration

Wegovy treatment follows a structured five-month dose-escalation schedule before reaching the maintenance dose. Weeks 1-4 begin at 0.25mg once weekly, followed by 0.5mg during weeks 5-8 [1]. The dose then increases to 1mg for weeks 9-12, then 1.7mg for weeks 13-16, before reaching the full maintenance dose of 2.4mg from week 17 onwards.

This gradual approach mirrors the STEP clinical trial protocols that demonstrated average weight reductions of 14.9% over 68 weeks in adults with obesity [2]. Patients who adhered to the complete titration schedule experienced significantly fewer treatment discontinuations due to gastrointestinal adverse events compared to those who attempted faster dose increases.

What to Expect at the Wegovy 0.5mg Dose

When you reach the 0.5mg dose during your second month of Wegovy treatment, you may notice increased appetite suppression compared to the initial 0.25mg phase. Many patients report feeling fuller for longer periods and experiencing reduced food cravings at this stage [2]. Weight loss typically becomes more noticeable during the 0.5mg phase, though individual responses vary considerably.

Gastrointestinal side effects remain the most common concern at 0.5mg, though they're generally milder than if you had started at this dose without the initial titration period. Approximately 44% of patients in the STEP trials reported nausea at some point during treatment, but symptoms were typically mild to moderate and decreased over time [2]. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise discomfort.

Your UK prescriber may recommend staying at the 0.5mg dose for longer than the standard four weeks if you experience persistent side effects, or if you're achieving satisfactory weight loss at this level. Dose adjustments are always made on an individual basis, prioritising both safety and efficacy.

Starting Wegovy 0.5mg: Clinical Outcomes and Expectations

Weight Loss Results During Early Titration

During the first two months of Wegovy treatment (0.25mg and 0.5mg phases), patients in the STEP-1 trial lost an average of 6% of their initial body weight [2]. This early weight reduction, whilst modest compared to results at the full 2.4mg maintenance dose, provides important early motivation and demonstrates treatment efficacy.

It's essential to maintain realistic expectations during the titration phase. The primary goal of the 0.25mg and 0.5mg doses is safe dose escalation, not maximum weight loss. The most significant weight reduction occurs after reaching and maintaining the 2.4mg dose, typically from month five onwards. Patients who discontinued treatment early due to unrealistic expectations during titration missed the substantial benefits seen in later treatment phases.

Wegovy 0.5mg vs Other Weight Loss Injections

Understanding how Wegovy's 0.5mg titration dose compares to other injectable weight loss treatments helps contextualise your treatment journey. Saxenda (liraglutide) uses a different titration schedule, starting at 0.6mg daily and increasing by 0.6mg increments every week until reaching 3mg daily [3]. The daily injection requirement and faster titration make Saxenda's side effect profile quite different from Wegovy's once-weekly regimen.

Mounjaro (tirzepatide), the newer dual GIP/GLP-1 receptor agonist, follows a similar gradual escalation approach to Wegovy but starts at 2.5mg once weekly before increasing to 5mg, then potentially 7.5mg, 10mg, 12.5mg, or 15mg depending on clinical response [4]. Whilst Mounjaro demonstrated superior weight loss outcomes in head-to-head trials (average 22.5% body weight reduction in SURPASS-2 versus 14.9% with semaglutide), both medications require careful dose titration for optimal tolerability.

Your UK prescriber will consider multiple factors when recommending the most appropriate treatment, including your medical history, weight loss goals, injection frequency preference, and budget. All injectable weight loss medications available through Cured Pharmacy require prescription authorisation following clinical assessment.

Accessing Wegovy 0.5mg Through UK Online Pharmacies

Safe Prescription Access at Cured Pharmacy

Wegovy is available from Cured Pharmacy from £79.00, representing competitive UK pricing with transparent costs shown before your consultation. Our GPhC-registered pharmacy (9012511) dispenses only genuine UK-licensed Wegovy pens, with each prescription reviewed by superintendent pharmacist Tarun Kumar (GPhC 2233073) or another qualified member of our clinical team.

The consultation process takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy. If Wegovy is deemed clinically appropriate, your prescription will specify the correct starting dose (0.25mg) and provide guidance on the titration schedule through to 0.5mg and beyond. Your medication is dispatched in 100% discreet packaging with next-day delivery options available across the UK.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Novo Nordisk. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/2313
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.